On December 15, 2020 CEELM gathered legal experts from across the region for its annual Year-in-Review Round Table conversation. In a wide-ranging discussion, participants shared opinions and perspectives on their markets, on strong (and less-strong) practices across the region, and the effect of the COVID-19 crisis on both, as well as on how technology is changing the legal industry, and what the industry will look like in 2021.
Cipcic-Bragadin Mesic & Associates has advised Pfizer on a global business combination with Mylan N.V. The transaction involved a spin-off of Pfizer’s Upjohn business and a subsequent merger of that business with Mylan N.V. to form a new global generics company, called "Viatris." Bird & Bird was global lead counsel to Pfizer, with Karanovic & Partners providing local support for Serbia and Jadek & Pensa providing local support in Slovenia.
Love them or hate them, conferences are a fundamental part of the successful commercial lawyer’s calendar. But time is precious. Those calendars are full. It’s vital for conference organizers to get them right, and critical for lawyers to choose wisely in determining which events to attend and which to skip.
Croatia's Cipcic‑Bragadin law firm has merged with the independent legal practices of Marina Mesic and Ivan Juricic. Following what it calls "the trilateral merger," Marina Mesic becomes a new named partner and Ivan Juricic joins as a senior partner at the firm, which will operate going forward as Cipcic‑Bragadin Mesic and Associates.